{
  "docId": "019de076-57a4-77f9-94ab-9b0feede6704",
  "docSlug": "a14e4b0042ed971c9f1fd15d53e19956",
  "documentTitle": "MaxCyte | Results Presentation Deck | 25 slides",
  "authorId": "maxcyte",
  "authorName": "MaxCyte",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2023-11-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 6,
  "pageCount": 25,
  "prevPage": 5,
  "nextPage": 7,
  "slideType": "kpi_overview",
  "function": "analyze_data",
  "density": "overcrowded",
  "nDataPoints": 10,
  "notes": null,
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de076-57a4-77f9-94ab-9b0feede6704/6",
  "deckHref": "/decks/019de076-57a4-77f9-94ab-9b0feede6704",
  "deckJsonHref": "/decks/019de076-57a4-77f9-94ab-9b0feede6704.json",
  "deckAnchorHref": "/decks/019de076-57a4-77f9-94ab-9b0feede6704#slide-6",
  "components": [
    {
      "bbox": {
        "h": 0.4,
        "w": 0.45,
        "x": 0.05,
        "y": 0.48
      },
      "kind": "chart",
      "text": "Projected sales of gene-modified cell therapies by 2026",
      "attrs": null,
      "subkind": "bar-vertical",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "1e2c0a4c-3262-4998-9f25-2e809620bf62",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.35,
        "w": 0.35,
        "x": 0.6,
        "y": 0.48
      },
      "kind": "list",
      "text": "2022 was focused on innovation and complexity: \"Other\" cell types grew 129%; Allogeneic therapies increased 33% vs autologous 23%; Rapid growth in cell targets.",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "0f045c13-81b3-4799-8644-89c6129fc7e6",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.1,
        "w": 0.15,
        "x": 0.3,
        "y": 0.18
      },
      "kind": "metric",
      "text": "650+",
      "attrs": null,
      "subkind": "big-number",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "24dc9f68-1a35-4c66-9326-1cb9f1b0070e",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.1,
        "w": 0.15,
        "x": 0.08,
        "y": 0.18
      },
      "kind": "metric",
      "text": "1,800+",
      "attrs": null,
      "subkind": "big-number",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "2bdde93f-d6d0-44cb-a638-452641ef7223",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.1,
        "w": 0.05,
        "x": 0.52,
        "y": 0.18
      },
      "kind": "metric",
      "text": "6",
      "attrs": null,
      "subkind": "big-number",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "904b68ef-fb19-47d1-9111-3a33fe30d2da",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.08,
        "w": 0.15,
        "x": 0.74,
        "y": 0.28
      },
      "kind": "metric",
      "text": "$12.6B",
      "attrs": null,
      "subkind": "big-number",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "ac48b54e-3b03-46ea-925e-fe8b043d0288",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.1,
        "w": 0.9,
        "x": 0.05,
        "y": 0.85
      },
      "kind": "source-note",
      "text": "Source: Evaluate Pharma; Alliance for Regenerative Medicine; Saez-Ibañez, et al. Nature News, June 2022.",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "dd5b25e4-d876-4d4c-b79f-9f681709fb4d",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.5,
        "x": 0.04,
        "y": 0.06
      },
      "kind": "title",
      "text": "Continued Investment in Cell and Gene Therapy",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "1801cd3b-50f1-40b5-a53c-d099f922668a",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 8,
      "from": 6,
      "beatId": "a8e9ed8e-5423-4b14-a02d-57b5166ec8fd",
      "arcName": "The Sequoia Pitch",
      "arcSlug": "sequoia-pitch",
      "beatName": "Solution",
      "beatSlug": "sequoia-pitch-solution",
      "evidence": "Slides 6-8 present MaxCyte's ExPERT platform and partnerships",
      "position": 1,
      "confidence": 0.8,
      "parentBeatName": "Turn",
      "parentBeatSlug": "turn"
    }
  ],
  "loops": [
    {
      "to": 8,
      "from": 5,
      "name": "Cost Of Inaction",
      "slug": "27-cost-of-inaction",
      "bestFor": "Urgent budget requests, compliance, risk mitigation",
      "matchId": "bd05f8b9-dd76-46e4-81a1-1bcb8b9816d9",
      "evidence": "Slides 5-8 imply the consequences of not using MaxCyte's technology",
      "position": 0,
      "objective": "Highlight the cost of not addressing industry challenges",
      "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
      "confidence": 0.7,
      "description": "Quantify what happens if the audience does nothing"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}